Metraipolis › archive › dc_6ddf67e3482f

Engineering HER2-targeted biparatopic antibodies to promote receptor internalization and restore antitumor efficacy — Europe PMC PMID:41280936

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41280936
DOI
10.3389/fimmu.2025.1711433
License (as archived)
solo-consultazione
Archived
2026-11-08T17:29:00.834Z
SHA-256 of the archived text
335bfde926cb041edb3c9cc7a7a4754fb069d16923d61336243fcc050889180c
Stable URL of this page
https://metraipolis.com/documento/dc_6ddf67e3482f

How to cite

Engineering HER2-targeted biparatopic antibodies to promote receptor internalization and restore antitumor efficacy — Europe PMC PMID:41280936 — Europe PMC (en), https://europepmc.org/article/MED/41280936 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6ddf67e3482f (Metraipolis archive dc_6ddf67e3482f, sha256 335bfde926cb041edb3c9cc7a7a4754fb069d16923d61336243fcc050889180c)
BibTeX
@misc{dc6ddf67e3482f,
  title = {Engineering HER2-targeted biparatopic antibodies to promote receptor internalization and restore antitumor efficacy — Europe PMC PMID:41280936},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41280936},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6ddf67e3482f; sha256 335bfde926cb041edb3c9cc7a7a4754fb069d16923d61336243fcc050889180c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41280936. Agents can read the archived copy with the MCP tool read_document.